Anti–IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
J. Clin. Invest. Yi Chen, et al. 116:1317
doi:10.1172/JCI25308 [Go to this article.]

Problems with a PDF?